+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Specimen Validity Test"

Specimen Validity Test Service Market - Global Forecast 2026-2032 - Product Thumbnail Image

Specimen Validity Test Service Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
Specimen Validity Testing Market Report 2026 - Product Thumbnail Image

Specimen Validity Testing Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Specimen Validity Testing - Global Strategic Business Report - Product Thumbnail Image

Specimen Validity Testing - Global Strategic Business Report

  • Report
  • September 2026
  • 225 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Specimen Validity Test (SVT) market is a segment of the In Vitro Diagnostics (IVD) industry. It is focused on the development and commercialization of tests that assess the integrity of biological samples used in laboratory testing. These tests are used to detect adulteration, substitution, and dilution of samples, which can lead to inaccurate results. SVT products are used in a variety of clinical settings, including drug testing, forensic toxicology, and clinical chemistry. The SVT market is driven by the increasing demand for accurate and reliable laboratory testing results. This is due to the growing prevalence of chronic diseases, the need for accurate diagnosis, and the increasing use of laboratory testing in clinical settings. Additionally, the increasing adoption of point-of-care testing and the development of new technologies are expected to drive the growth of the SVT market. Some of the major companies in the SVT market include Siemens Healthineers, Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, and Roche Diagnostics. Show Less Read more